Setup: RocketBase
VCP: 9W 38/4 4T
RS: 89
The posted chart contains a VCP (volatility contraction pattern). The first label "W" stands for weekly and shows the duration of the entire consolidation. In the middle label, the percentage of contractions is indicated (for example, "15/4"), with 15 representing the -15% depth of the base and 4 representing -4% of the...
Bullish Pennant (51%)
Pros:
Volume during post formation
Descending volume during triangle formation
Golden cross in blue
PPS above 50MA and 200MA
RS above 0
R/R ratio above 5
ATR ascending
250RSI above 50 and ascending
200MA ascending
Cona:
RS Flat
Target:
PT = 5.45$
Help how ever you can to keep this alive.
Thank you to those who have donated Coins!
Always do...
Oncolytics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Patrick Trucchio initiated coverage of Oncolytics Biotech with a Buy rating and $15 price target. The company is "on the cusp of demonstrating potential to upend the treatment paradigms of several cancers," Trucchio tells investors in a research note. He believes Oncolytics is well...
Long term downtrend line broken. V shaped upswing with much increased volume. It has a well patented potential product that has great promise in assisting in treatment of difficult cancers. Like all small biotech companies there is often a lot of volatility and risk. I'm looking for a rise to 9-15. Yesterday jump due to Buy rating with target of 15 by HC...
Could flag again if it breaks above 3.66. Stop signal 3.19. Smaller position to offset stop risk. Target 4.23(acorn is already holding an active position in this)
More information was necessary to form this decision. Time and patience. ONCY has stayed in the ascending channel well. I will buy here, but this is not financial advice.
This has room to move down within the ascending channel, but is on a level of horizontal support right now. Just keeping levels in mind. I will likely buy a small position here and will add more if it reaches the low of the channel. Happy trading!
Here is a great opportunity to go long on ONCY .
At Three Percent Trades we have a price target of $4.00 - $7.00 / share, which is a potential upside of 52 - 167% from the current level.
We use a combination of fundamentals & technical analysis to trade high probability set-ups, and believe this is a great opportunity to take advantage.
Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew...
On the verge of breaking the 100ma resistance which sits in confluence withe .382 fib as current barrier to a bullish move higher.25% upside
Possible
Average analysts price target $6.93 and BUY rating
Company profile
Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological...
